Dividend alert: MRF, Cochin Shipyard, Talbros and others may reward shareholders this week - Check key dates, returns

Revolution Medicines' Pancreatic Cancer Drug Nearly Doubled Survival. Is the High-Flying Stock Still a Buy?

NASDAQ · Markets 1h ago

Forget the 2026 Midterm Election Results. Warren Buffett's Advice Makes This ETF a No-Brainer Buy

NASDAQ · Markets 1h ago

Can the Blue Wave Save Renewable Energy Stocks?

NASDAQ · Markets 1h ago

This Dividend King Has Raised Its Payout Through Every Recession Since the 1950s. I'm Buying Before the End of the Year.

NASDAQ · Markets 1h ago

AI Stocks Crashed by Blue Wave: What Comes Next?

NASDAQ · Markets 1h ago

Billionaire Bill Ackman Has Been All-In on Uber. Is Now the Time to Buy the Stock?

NASDAQ · Markets 1h ago

Broadcom Stock Has Lost Nearly 40% From Its Record. I'd Buy It Now.

NASDAQ · Markets 1h ago

Why the Iran War Has Spurred Both Clean Energy and Fossil Fuels

The New York Times · Business 2h ago

Why Royalty Pharma Investors Could Be the Quiet Winners From Revolution Medicines' Groundbreaking Pancreatic Cancer Drug

NASDAQ · Markets 2h ago

Why Qualcomm Stock Fell 9% Despite Beating Earnings Estimates

NASDAQ · Markets 2h ago